The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 15, 2017
Filed:
Aug. 11, 2014
Applicant:
Advanced Bionutrition Corporation, Columbia, MD (US);
Inventors:
Moti Harel, Pikesville, MD (US);
Roger Drewes, Hockessin, DE (US);
January Scarbrough, Silver Spring, MD (US);
Assignee:
Advanced Bionutrition Corp., Columbia, MD (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A01N 31/04 (2006.01); A61K 47/36 (2006.01); A23L 1/30 (2006.01); A23K 1/00 (2006.01); A23L 1/29 (2006.01); A23L 2/52 (2006.01); A61K 35/74 (2015.01); A23K 1/18 (2006.01); A01N 63/00 (2006.01); A61K 31/07 (2006.01); A61K 38/48 (2006.01); A01N 63/02 (2006.01); A61K 47/38 (2006.01); A61K 9/16 (2006.01); A61K 9/19 (2006.01); A61K 35/742 (2015.01); A23K 10/18 (2016.01); A23K 50/80 (2016.01); A23L 33/00 (2016.01); A23L 33/135 (2016.01);
U.S. Cl.
CPC ...
A61K 47/38 (2013.01); A01N 31/04 (2013.01); A01N 63/00 (2013.01); A01N 63/02 (2013.01); A23K 10/18 (2016.05); A23K 50/80 (2016.05); A23L 2/52 (2013.01); A23L 33/135 (2016.08); A23L 33/40 (2016.08); A61K 9/1623 (2013.01); A61K 9/1652 (2013.01); A61K 9/1658 (2013.01); A61K 9/19 (2013.01); A61K 31/07 (2013.01); A61K 35/74 (2013.01); A61K 35/742 (2013.01); A61K 38/482 (2013.01); A61K 47/36 (2013.01); A23V 2002/00 (2013.01); A23Y 2220/73 (2013.01); A23Y 2300/49 (2013.01); C12Y 304/21062 (2013.01);
Abstract
The present invention relates to formulations and methods for stabilizing and protecting of biologic materials during harsh storing and use conditions, wherein the formulations relate to embedded bioactive materials and biologics, including live bacteria, in a protective glassy matrix.